COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,100 Articles (22,658 medRxiv, 8,442 bioRxiv)

Most recent first Previous |  Page 595: Articles 5941-5950  | Next

Fate and plasticity of SARS-CoV-2-specific B cells during memory and recall response in humans
Zurbuchen, Y., Michler, J., Taeschler, P., Adamo, S., Cervia, C., Raeber, M. E., Acar, I. E., Nilsson, J., Soyka, M. B., Moor, A. E., Boyman, O.
10.1101/2022.10.07.511336 — Posted: 2022-10-07
Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice
Jang, Y., Cho, H., Chun, J., Park, K., Nowakowska, A., Kim, J., Lee, H., Lee, C., Han, Y., Lee, H.-J., Shin, H.-Y., Kim, Y. B.
10.1101/2022.10.07.511252 — Posted: 2022-10-07
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domains
Stewart-Jones, G., Elbashir, S. M., Wu, K., Lee, D., Renzi, I., Ying, B., Koch, M., Sein, C. E., Choi, A., Whitener, B., Garcia-Dominguez, D., Henry, C., Woods, A., Ma, L., Montes Berrueta, D., Avena, L. E., Quinones, J., Falcone, S., Hsiao, C. J., Scheaffer, S. M., Thackray, L. B., White, P., Diamond, M. S., Edwards, D. K., Carfi, A.
10.1101/2022.10.07.511319 — Posted: 2022-10-07
Neutralization of SARS-CoV-2 Omicron BA.4/BA.5 subvariant by a booster dose of bivalent adjuvanted subunit vaccine containing Omicron BA.4/BA.5 and BA.1 subvariants
Kuo, T.-Y., Lien, C. E., Lin, Y.-J., Lin, M.-Y., Liu, L. T.-C., Wu, C.-C., Tang, W.-H., Chen, C.
10.1101/2022.10.07.511263 — Posted: 2022-10-07
Incipient parallel evolution of SARS-CoV-2 Deltacron variant in South Brazil
Sant Anna, F. H., Andreis, T. F., Salvato, R. S., Muterle, A. P., Comerlato, J., Gregianini, T. S., Barcellos, R. B., Godinho, F. M., Resende, P. C., Wallau, G. L., Castro, T. R., Casarin, B. C., Vieira, A. A., Schwarzbold, A. V., Trindade, P. A., Giannini, G. L., Freese, L., Bristot, G., Brasil, C. S., Rocha, B. O., Martins, P. B., Oliveira, F. H., Oosterhout, C. v., Wendland, E.
10.1101/2022.10.06.511203 — Posted: 2022-10-07
Long COVID Risk and Pre-COVID Vaccination: An EHR-Based Cohort Study from the RECOVER Program
Brannock, M. D., Chew, R. F., Preiss, A. J., Hadley, E. C., McMurry, J. A., Leese, P. J., Girvin, A. T., Crosskey, M., Zhou, A. G., Moffitt, R. A., Jonsson Funk, M., Pfaff, E., Haendel, M., Chute, C. G., N3C Consortium, , RECOVER Consortium
10.1101/2022.10.06.22280795 — Posted: 2022-10-07
Impact of vaccination on post-acute sequelae of SARS CoV-2 infection in patients with rheumatic diseases
Patel, N. J., Cook, C., Vanni, K. M., Fu, X., Wang, X., Kawano, Y., Qian, G., Hang, B., Srivatsan, S., Banasiak, E., Kowalski, E., Bade, K., Zhang, Y., Sparks, J. A., Wallace, Z. S.
10.1101/2022.10.06.22280798 — Posted: 2022-10-07
COVID-19: impact of original, Gamma, Delta, and Omicron variants of SARS-CoV-2 in vaccinated and unvaccinated pregnant and postpartum women
Serra, F., Rosa, E. R., de Rossi, P., Francisco, R. P., Rodrigues, A. S.
10.1101/2022.10.05.22280754 — Posted: 2022-10-07
The Incidence of Immune Mediated Inflammatory Diseases Following COVID-19: a Matched Cohort Study in UK Primary Care
Syed, U., Subramanian, A., Wraith, D., Lord, J. M., Mcgee, K. C., Ghokale, K. M., Nirantharakumar, K., Haroon, S.
10.1101/2022.10.06.22280775 — Posted: 2022-10-07
Risk factors for household transmission of SARS-Cov-2: a modelling study in the French national population-based EpiCov cohort
Novelli, S., Opatowski, L., Manto, C., Rahib, D., de Lamballerie, X., Warszawski, J., Meyer, L.
10.1101/2022.10.06.22280739 — Posted: 2022-10-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).